L de Leij

930 total citations
26 papers, 707 citations indexed

About

L de Leij is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, L de Leij has authored 26 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in L de Leij's work include Monoclonal and Polyclonal Antibodies Research (15 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). L de Leij is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). L de Leij collaborates with scholars based in Netherlands, United States and Mexico. L de Leij's co-authors include S Poppema, T H Thé, Pieter E. Postmus, B. J. Kroesen, Wijnand Helfrich, Henk H. Berendsen, A. ter Haar, Grietje Molema, Hao Chung The and Adriana Boes and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and CHEST Journal.

In The Last Decade

L de Leij

26 papers receiving 662 citations

Peers

L de Leij

ONCOL

RNMI

IMMUN

EPIDE

Philip Rümke Netherlands

Qingyu Cheng Germany

David J. Munster Australia

Kate Poropatich United States

Diego Alignani Spain

F Rousset France

Kathleen F. Bongiovanni United States

Sumi Scott United States

Nancy Collins United States

Keri Csencsits‐Smith United States

Philip Rümke Netherlands

L de Leij

217 ×0.7

ONCOL

189 ×0.7

146 ×0.6

RNMI

389 ×1.7

IMMUN

40 ×0.2

EPIDE

Citations per year, relative to L de Leij L de Leij (= 1×) peers Philip Rümke

Countries citing papers authored by L de Leij

Since Specialization

Citations

This map shows the geographic impact of L de Leij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L de Leij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L de Leij more than expected).

Fields of papers citing papers by L de Leij

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L de Leij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L de Leij. The network helps show where L de Leij may publish in the future.

Co-authorship network of co-authors of L de Leij

This figure shows the co-authorship network connecting the top 25 collaborators of L de Leij. A scholar is included among the top collaborators of L de Leij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L de Leij. L de Leij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Withoff, Sebo, et al.. (2001). Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells. British Journal of Cancer. 84(8). 1115–1121. 5 indexed citations

Withoff, Sebo, Wijnand Helfrich, L de Leij, & Grietje Molema. (2001). Bi-specific antibody therapy for the treatment of cancer.. PubMed. 3(1). 53–62. 40 indexed citations

Roovers, Rob C., Paula Henderikx, Wijnand Helfrich, et al.. (1998). High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting. British Journal of Cancer. 78(11). 1407–1416. 47 indexed citations

Zanten, Jet Veldhuijzen, et al.. (1998). Human cytomegalovirus: a viral complication in transplantation. Clinical Transplantation. 12(3). 145–158. 11 indexed citations

Harmsen, Martin C., et al.. (1997). Studies on the Induction of Antigen‐Specific Antibody in Anti‐CD40 Cultured Human B Lymphocytes. Journal of Immunology Research. 6(3-4). 261–271. 1 indexed citations

Kroesen, B. J., et al.. (1996). The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity. British Journal of Cancer. 73(6). 721–727. 9 indexed citations

Sleijfer, D.Th., et al.. (1996). Outpatient-based Subcutaneous Interleukin-2 Monotherapy in Advanced Renal Cell Carcinoma: an Update. Cancer Biotherapy and Radiopharmaceuticals. 11(5). 289–295. 4 indexed citations

Kroesen, Bart‐Jan, René A. J. Janssen, Jan Buter, et al.. (1995). Bispecific Monoclonal Antibodies for Intravenous Treatment of Carcinoma Patients: Immunobiologic Aspects. Journal of Hematotherapy. 4(5). 409–414. 9 indexed citations

Janssen, René A. J., Jan Buter, G Mesander, et al.. (1995). Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients. British Journal of Cancer. 72(3). 795–799. 10 indexed citations

10.

Savelkoul, Huub F. J., et al.. (1995). Impaired Antigen‐Specific B‐Cell Response and Altered Splenic Microstructure in Mice Following Continuous Administration of IL‐4 In Vivo. Scandinavian Journal of Immunology. 41(5). 467–474. 1 indexed citations

11.

Zanten, Jet Veldhuijzen, Martin C. Harmsen, Pieter F. van der Meer, et al.. (1995). Proliferative T Cell Responses to Four Human Cytomegalovirus-Specific Proteins in Healthy Subjects and Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 172(3). 879–882. 29 indexed citations

12.

Kroesen, B. J., Arjen Q. Bakker, René A. W. van Lier, Hauw The, & L de Leij. (1995). Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28.. PubMed. 55(19). 4409–15. 31 indexed citations

13.

Venema, Koen, Tjakko Abee, A J Haandrikman, et al.. (1994). Mode of action of LciA, the lactococcin A immunity protein. Molecular Microbiology. 14(3). 521–532. 67 indexed citations

14.

Kroesen, B. J., Jan Buter, D.Th. Sleijfer, et al.. (1994). Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. British Journal of Cancer. 70(4). 652–661. 74 indexed citations

15.

Martens, Ann, et al.. (1993). Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. British Journal of Cancer. 67(5). 1118–1121. 8 indexed citations

16.

Kroesen, B. J., et al.. (1992). Increased production of antigen-specific B lymphocytes during in vitro immunization using carrier-specific T helper hybridomas. Journal of Immunological Methods. 153(1-2). 49–56. 6 indexed citations

17.

Leij, L de, et al.. (1989). Detection and isolation of antigen-specific B cells by the fluorescence activated cell sorter (FACS). Journal of Immunological Methods. 117(2). 275–284. 12 indexed citations

18.

Berendsen, Henk H., L de Leij, S Poppema, et al.. (1989). Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.. Journal of Clinical Oncology. 7(11). 1614–1620. 99 indexed citations

19.

Kallenberg, C. G. M., et al.. (1987). Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis.. Journal of Clinical Pathology. 40(7). 725–733. 30 indexed citations

20.

Poppema, S, E.-B. Bröcker, L de Leij, et al.. (1983). In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.. PubMed. 51(1). 77–82. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact